Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AE Sphingosine-1-phosphate (S1P) receptor modulators
L04AE01 Fingolimod
D10001 Fingolimod (INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02980 CYP4F2 substrate
DG00741 Fingolimod
D10001 Fingolimod
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Sphingolipid
S1PR1
D10001 Fingolimod (INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10001
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10001
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02980 CYP4F2 substrate
DG00741 Fingolimod